Exelixis, Inc. (EXEL)
50.13
-0.97
(-1.90%)
USD |
NASDAQ |
May 15, 16:00
49.86
-0.27
(-0.54%)
Pre-Market: 09:05
Exelixis Total Assets (Quarterly) : 2.594B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 128.68B |
| Madrigal Pharmaceuticals, Inc. | 1.227B |
| Krystal Biotech, Inc. | 1.397B |
| Arcus Biosciences, Inc. | 997.00M |
| Immunome, Inc. | 619.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 657.84M |
| Shareholders Equity (Quarterly) | 1.936B |
| Debt to Equity Ratio | 0.0876 |
| Current Ratio | 3.258 |
| Net Debt Paydown Yield | 0.09% |